{"url_path":"/sec/cvsi/8-k/2026-06-04/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1510964/0001193125-26-257417-index.html","accession_number":"0001193125-26-257417","cik":"0001510964","ticker":"CVSI","issuer_name":"CV Sciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1510964/0001193125-26-257417-index.html","primary_entity_key":"0001510964","primary_entity_name":"CV Sciences, Inc."},"word_count":354,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nOn June 2, 2026, CV Sciences, Inc. (the \"Company\") held the 2026 Annual Meeting in a virtual format. At the close of business on April 6, 2026, the record date for the 2026 Annual Meeting, there were 193,458,420 shares of common stock issued and outstanding, which constituted all of the outstanding capital stock of the Company.\n\nAt the 2026 Annual Meeting, 116,234,784 of the 193,458,420 outstanding shares of common stock entitled to vote, or approximately 60.1%, were represented by proxy at the meeting, and, therefore, a quorum was present. The proposals voted on at the 2026 Annual Meeting are more fully described in Proxy Statement, which is incorporated herein by reference.\n\nThe final voting results on the proposals presented for stockholder approval at the 2026 Annual Meeting were as follows:\n\n \n\nProposal 1 - Election of Directors\n\nThe Company's stockholders elected three directors, each to serve until the Company's next Annual Meeting of Stockholders or until his successor is duly elected and qualified, subject to prior death, resignation or removal, as set forth below:\n\n \n\nNAME\n\nFOR\n\nAGAINST\n\nABSTAIN\n\nBROKER NON-VOTE\n\nDr. Jamie Corroon\n\n39,505,495\n\n3,183,772\n\n1,078,738\n\n72,466,779\n\nJoseph Dowling\n\n37,674,977\n\n4,813,319\n\n1,279,709\n\n72,466,779\n\nBill McCorkle\n\n22,671,092\n\n3,928,542\n\n17,168,371\n\n72,466,779\n\n \n\nProposal 2 - Reverse Stock Split\n\nThe Company's stockholders did not approve the Company's proposal to amend its Certificate of Incorporation, as amended to effect, at the discretion of the Board of Directors, a reverse stock split of all outstanding shares of common stock at a ratio of not less than 1-for-10 and not greater than 1-for-800, such ratio to be determined by the Board of Directors at any time before May 30, 2029, without further approval or authorization from its stockholders, as set forth below:\n\n \n\nFOR\n\nAGAINST\n\nABSTAIN\n\nBROKER NON-VOTE\n\n48,496,747\n\n59,628,926\n\n8,109,111\n\n-\n\n \n\nProposal 3 - Ratification of Selection of Independent Registered Public Accounting Firm\n\nThe Company's stockholders ratified Haskell & White LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, as set forth below:\n\n \n\nFOR\n\nAGAINST\n\nABSTAIN\n\nBROKER NON-VOTE\n\n102,384,289\n\n12,488,529\n\n1,361,966\n\n-\n\n \n\n1"}